Over the next five years, we plan to design, fund, and launch animal lifespan studies for the most promising longevity interventions. Here’s how we’ll do that — and where your donations will go.
A mouse lifespan study, with 50 mice in the treatment group and 50 control mice, would cost roughly $200,000-500,000 depending on the additional tests we’d run (blood work, activity levels and cognitive tests, biopsies, etc.)
A short-term mouse study, such as administering a drug to aged mice for a few months and testing them for measures of strength, endurance, cognitive function, metabolic parameters, or aging-related disease, would cost an estimated $50,000.
Publication and presentation costs (including journal submission costs, conference travel and posters, and writing/editing/statistical analysis where relevant) would be a few thousand dollars per experiment.
Operating costs for the nonprofit include lawyers, accountants, incorporation fees, a website, and salaries.
Incorporate nonprofit ($4000 in legal and incorporation fees)
Set up website ( $2300 for professional design)
Initial Fundraising
Contact researchers and investigate opportunities to fund experiments
Launch two mouse lifespan studies with CROs ($500,000-1,000,000)
Publicize study launch
Continue initial fundraising push
3-month preliminary tests for aging symptoms & biomarkers
Contact researchers and launch two more short-term mouse studies for additional compounds ($100,000)
Receive and analyze 3-month study results; prepare and submit for publication if noteworthy
Publicize interim results and study launches
If promising, continue these as lifespan studies ($500,000-1,000,000)
Launch two more short-term mouse studies ($100,000)
Publicize interim results and study launches
$700,000 - 2,200,000
~$20,000
$7,000
$145,000
$865,000 - $2,372,000
If we find a treatment that succeeds in animals, we could begin human experiments.
The first mouse lifespan studies could show results as early as 2020.
The next step from there would be a human safety study, followed by a controlled longitudinal all-cause mortality study in elderly subjects. Within 6-10 years, we’d have early evidence on whether the treatment reduces mortality or the incidence of age-related disease.
2-4 mouse lifespan studies launched, 4 interim studies completed
Projected costs: $2M
2-4 mouse lifespan studies launched, 8 interim studies completed
Projected costs: $2M
2-4 mouse lifespan studies launched, 8 interim studies completed
Projected costs: $2M
2-4 mouse lifespan studies launched, 8 interim studies completed, 2 lifespan studies completed, human safety trial(s) launched
Projected costs: $6M
2-4 lifespan studies completed, human mortality study launched
Projected costs: ?
We need your help to make LRI’s mission a reality. Donations allow us to test more treatments in parallel, test more animal models and measures of aging-related disease, and get results faster.